FGF-2 TOP (THERMOSTABILITY OPTIMIZED)
Dead / Abandoned — Abandoned — failure to respond (as of 27 May 2025)
What this means for you
This application is over — abandoned 12 May 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98601491
- Mark type
- Design + words
- Filed
- 14 Jun 2024
- Abandoned
- 12 May 2025
- Attorney of record
- James R. Robinson
Goods and services
- Class 001 — Chemicals: Chemicals for use in industry and science, namely, proteins for use in industry and science and other molecules for use in industry and science; proteins and other molecules for use in the following fields: medical research; proteins and other molecules used as industrial chemicals for manufacturing or as ingredients in cell culture media and diagnostic preparations; proteins and other biological molecules used for manufacturing or as ingredients in pharmaceuticals (biopharmaceuticals); enzymes and other molecules for use in industry and science; biological preparations for use in industry and science; cell growth media for use in the following fields: scientific research, biological research and biotechnological research; biological preparations, namely, proteins, living cells, lab-grown living cells for use in industry and science; proteins and other molecules for use in the following fields: biological research; recombinant proteins.
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations; stem cells for medical purposes, for clinical use, for pharmaceutical purposes and veterinary purposes; cell growth media for growing cells for medical purposes, for clinical use, for pharmaceutical purposes and veterinary purposes; chemical preparations for medical purposes, for clinical use, for pharmaceutical purposes and veterinary purposes; biological preparations for medical purposes, for clinical use, for pharmaceutical purposes and veterinary purposes; bacterial preparations for medical purposes, for clinical use, for pharmaceutical purposes and veterinary purposes; microbiological culture media for medical purposes, for clinical use, for pharmaceutical purposes and veterinary purposes; enzyme preparations for medical purposes, for clinical use, for pharmaceutical purposes and veterinary purposes; diagnostic preparations for medical purposes, for clinical use, for pharmaceutical purposes and veterinary purposes; biological preparations in the form of cell products for medical purposes, for clinical use, for pharmaceutical purposes and veterinary purposes; recombinant growth factors, used in pharmaceuticals for research purposes; protein and other molecules for use in the following fields: cell therapy.
Owner
- Core Biogenesis, Illkirch-Graffenstaden, FR
Prosecution history
- 27 May 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 27 May 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 10 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 Feb 2025 — NON-FINAL ACTION E-MAILED
- 10 Feb 2025 — NON-FINAL ACTION WRITTEN
- 11 Jan 2025 — ASSIGNED TO EXAMINER
- 10 Jan 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 10 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 14 Jun 2024 — NEW APPLICATION ENTERED